Zobrazeno 1 - 10
of 23
pro vyhledávání: '"H. C. Watt"'
Publikováno v:
BMC Public Health, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Background Thinness during adolescence can increase the risk of adverse health outcomes across the life-course and impede development. There is limited research examining the prevalence and determinants of persistent adolescent thinness in t
Externí odkaz:
https://doaj.org/article/ef56f70b9edb43e3b34c2d2e986520df
Publikováno v:
International Journal of Electronics. 76:469-482
A universal active-R building block was successfully designed and implemented using semi-custom VLSI (analogue gate-array) technology. The circuit makes use of the inherent charge storage in the low-frequency PNP transistors buffered by high-frequenc
Autor:
N J, Wald, M, Law, H C, Watt, T, Wu, A, Bailey, A M, Johnson, W Y, Craig, T B, Ledue, J E, Haddow
Publikováno v:
The Lancet. 343:75-79
Apolipoproteins and lipids are established risk factors of ischaemic heart disease (IHD) but their efficacy as screening tests is not known. We therefore examined the mortality from IHD and serum concentrations of lipids and apolipoproteins in a pros
Publikováno v:
Journal of Materials Science Letters. 14:96-98
Wafer bonding is the dedicated joining of two semiconductor wafer surfaces without the use of adhesives. Specific applications include silicon-oninsulator (SOI), sensors and actuators, and threedimensional integrated microstructures [1-5]. Although a
Autor:
J, Dehmeshki, D T, Chard, S M, Leary, H C, Watt, N C, Silver, P S, Tofts, A J, Thompson, D H, Miller
Publikováno v:
Journal of neurology. 250(1)
In 10-15 % of patients with multiple sclerosis (MS), the clinical course is characterized by slow progression in disability without relapses (primary progressive (PP) MS). The mechanism of disability in this form of MS is poorly understood. Using mag
Publikováno v:
Prenatal diagnosis. 19(6)
We conducted a study to determine the value of serum pregnancy-specific beta-1-glycoprotein (Schwangerschafts protein 1, SP1) as an antenatal screening test for Down syndrome in the first trimester. Serum samples collected from women at 8 to 14 weeks
Publikováno v:
Prenatal diagnosis. 19(2)
It is recognized that pregnancies with Down syndrome are liable to end in spontaneous fetal loss. It is important to determine the magnitude of this effect so that it can be taken into account when assessing the results of antenatal screening program
Publikováno v:
Prenatal diagnosis. 18(8)
Serum markers used in screening for Down syndrome and neural tube defects are often adjusted to take account of the effect of maternal weight on the marker levels. The standard adjustment procedure is based on a linear relationship between the marker
Publikováno v:
Prenatal diagnosis. 18(8)
Maternal serum inhibin-A concentration is a useful marker in prenatal screening for Down syndrome in the second trimester. We measured inhibin-A concentrations in 4304 pregnancies without Down syndrome between 14 and 22 weeks of pregnancy to determin
Publikováno v:
Prenatal diagnosis. 18(3)
To investigate whether statistical parameters used in Down syndrome screening between 15 and 22 weeks of pregnancy can be used at 14 weeks, we assayed alpha-fetoprotein (AFP), unconjugated oestriol (uE3), total human chorionic gonadotrophin (hCG), fr